Carregant...
Gay and bisexual men’s strategies to maintain daily adherence to their HIV Pre-Exposure Prophylaxis (PrEP) medication: Results from a qualitative study
Since FDA approval in 2012, HIV pre-exposure prophylaxis (PrEP) has been adopted by key populations, including gay and bisexual men (GBM), to reduce their HIV transmission risk. Given that PrEP is optimally effective when taken as prescribed, it is critical to understand the adherence strategies GBM...
Guardat en:
| Publicat a: | Prev Sci |
|---|---|
| Autors principals: | , , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2019
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6438208/ https://ncbi.nlm.nih.gov/pubmed/30637602 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11121-019-0985-y |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|